- €307.43m
- €294.47m
- €15.39m
- 24
- 53
- 74
- 47
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | DAS | DAS | DAS | DAS | DAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 75.7 | 51.6 | 61.2 | 95.7 | 15.4 |
Cost of Revenue | |||||
Gross Profit | 70 | 45.6 | 54.6 | 87.3 | 8.27 |
Other Operating Expenses | |||||
Total Operating Expenses | 114 | -165 | -95.6 | -92.7 | 319 |
Operating Profit | -38.3 | 216 | 157 | 188 | -304 |
Net Income Before Taxes | -38.3 | 216 | 157 | 188 | -304 |
Net Income After Taxes | -38.3 | 216 | 157 | 188 | -304 |
Net Income Before Extraordinary Items | |||||
Net Income | -38.3 | 216 | 157 | 188 | -304 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -38.3 | 216 | 157 | 188 | -304 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.21 | 33.2 | 25.6 | 33.6 | -58.1 |
Dividends per Share |